SD

Saroj Devi

Active Director Director DIN 09343821
DIN 09343821 First appointment Oct 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Saroj Devi

Data last updated:

Saroj Devi is a Director at Knd Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Knd Pharmaceuticals Private Limited reported revenue of ₹1.12 Cr (FY 2025).

DIN 09343821
Primary Designation Director
Industry Trading
First Appointment 01 Oct 2021
Oldest Company Age 5 yrs
Largest company Knd Pharmaceuticals Private Limited · ₹1.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Knd Pharmaceuticals Private Limited U51909UP2021PTC153247
Director01 Oct 20212021₹1.12 Cr (FY 2025)Active

Board colleagues of Saroj Devi

NameDINCompanyDesignation
Komal Kumari09343820Knd Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Knd Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saroj Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saroj Devi

Saroj Devi currently holds 1 directorship: Knd Pharmaceuticals Private Limited (Director, since 01 Oct 2021, revenue ₹1.12 Cr (FY 2025)).

Saroj Devi was first appointed on 01 Oct 2021 as Director at Knd Pharmaceuticals Private Limited.

The current boards of Saroj Devi's companies include Komal Kumari (Knd Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available